Skip to main content
OpenTrials

Clinical trial condition

Metastatic Breast Cancer

Explore clinical trials studying Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

640 public trials 137 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Breast Cancer trial results

Active, Not Recruiting

Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer

NCT04115306

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Duarte, California, United States
  • City of Hope Orange County, Lennar Irvine, California, United States
  • University of California, Los Angeles (UCLA) Los Angeles, California, United States
View Trial Details
Active, Not Recruiting

A Study of the Efficacy, Safety and Pharmacokinetics of RPH-051 and Perjeta® in Combination With Trastuzumab and Docetaxel as the 1st Line Therapy in Patients With HER2-positive Breast Cancer

NCT07386938

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced Breast Cancer, +5 more
Locations
  • Regional Budgetary Healthcare Institution "Kursk Oncology Research and Clinical Center named after G.E. Ostroverhov" Kursk, Kursk Oblast, Russia
  • State Budgetary Healthcare Institution "Leningrad Regional Clinical Hospital" (SBHI "LOKH") Kuz'molovskiy, Leningradskaya Oblast', Russia
  • State Budgetary Healthcare Institution of Arkhangelsk Region "Arkhangelsk Clinical Oncology Dispensary" Arkhangelsk, Russia
  • Regional State Budgetary Healthcare Institution "Altai Regional Oncology Dispensary" Barnaul, Russia
View all 45 locations
View Trial Details
Active, Not Recruiting

A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer

NCT06557148

Conditions
Adenocarcinoma, Breast Cancer, Breast Carcinoma, +15 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (All protocol activity) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)

NCT06428396

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • City of Hope - Phoenix ( Site 0006) Goodyear, Arizona, United States
  • Cedars Sinai Medical Center ( Site 0012) Beverly Hills, California, United States
  • Moores Cancer Center at UC San Diego Health ( Site 0025) La Jolla, California, United States
  • USC/Norris Comprehensive Cancer Center ( Site 0013) Los Angeles, California, United States
View all 41 locations
View Trial Details
Active, Not Recruiting

Roll-over Study to Allow Continued Access to Ribociclib

NCT05161195

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Ironwood Cancer and Research Centers Chandler, Arizona, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • Poudre Valley Hospital Fort Collins, Colorado, United States
View all 73 locations
View Trial Details
Active, Not Recruiting

A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer

NCT04188548

Conditions
Advanced Breast Cancer, Breast Cancer, Breast Diseases, +17 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic in Arizona - Phoenix Phoenix, Arizona, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Beverly Hills Cancer Center Beverly Hills, California, United States
View all 74 locations
View Trial Details

Related conditions